Blood pressure drug joins fight against esophageal cancer
NCT ID NCT04682158
Summary
This study is testing whether adding propranolol, a common blood pressure medication, to standard chemoradiation treatment helps people with esophageal adenocarcinoma. Researchers want to see if this combination is safe and more effective at controlling the cancer. The trial will enroll about 106 patients who are already scheduled to receive standard treatment.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ESOPHAGEAL ADENOCARCINOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Roswell Park Cancer Institute
RECRUITINGBuffalo, New York, 14263, United States
Conditions
Explore the condition pages connected to this study.